EMBL Hamburg Logo
Travel and Contact  Staff Only  Site Map  Help?   
EMBL HamburgEuropean Molecular Biology Laboratory
EMBLEMBL GrenobleEMBL HamburgEMBL HeidelbergEMBL-EBI HinxtonEMBL Monterotondo
EMBL Hamburg > Courses and Conferences
 
Introduction
 
Programme
 
Sponsors
 
Speakers
 
Organizers
 
Materials
(restricted access)
 
L. Jeanne Perry -
Escherichia coli remains the most popular host for heterologous expression of recombinant proteins. The genetics of this bacterium are the most characterized and well studied of any microorganism. In addition, E. coli has many advantages over others hosts including its ease of handling, low cost, and efficient growth. However, there are several drawbacks that can hamper high-level expression of recombinant proteins for structural determination. Among the roadblocks are expression, solubility, folding and purity.

Currently we are involved in several structural genomics projects: Pyrobaculum aerophilum, Rhodopseudomonas palustris, Deinococcus radiodurans, Mycobacterium tuberculosis and others. Pyrobaculum aerophilum is a hyperthermophilic (Topt = 100C), facultatively aerobic, archeon. Its sequence contains 2.2 Mb, with 59% G + C (Fitzgibbon et al., 2002). The structural genomics of Pyrobaculum aerophilum will provide insights for understanding life in extreme conditions as well as shedding more light on this understudied branch of life. Mycobacterium tuberculosis, the infective agent that causes the disease tuberculosis (TB). One-third of the world's population are infected and about 3 million people die each year from TB. The genome of Mycobacterium tuberculosis contains 4.4 Mb, with a relatively high 66% G + C (Cole et al., 1998). Our approach to the Mycobacterium tuberculosis structural genomics project will yield information for drug-design and vaccine production against tuberculosis. In addition, we hope to provide further insights into the mechanisms of mycobacterial pathogenesis.

The results from these projects, relevant to the bottlenecks of protein production, as well as recent advances and improvements in expression technology will be presented. An overview of yeast expression will also be presented. The basic issues that hamper production of functional protein as well as strategies to overcome them will be discussed. Despite the roadblocks, the growing list of solved protein structures have continued to make Escherichia coli the expression host of choice for the production of many proteins for structural studies.